EMEA-001990-PIP01-16-M03

Table of contents

Key facts

Active substance
Fenfluramine hydrochloride
Therapeutic area
Neurology
Decision number
P/0475/2020
PIP number
EMEA-001990-PIP01-16-M03
Pharmaceutical form(s)
Oral solution
Condition(s) / indication(s)
Treatment of Dravet syndrome
Route(s) of administration
  • Oral use
  • Gastric use
Contact for public enquiries
Zogenix International Ltd (50405)

Email: medinfo.eu@zogenix.com
Tel. +44 7760626263
 

Decision type
PM: decision on the application for modification of an agreed PIP

Decision

How useful was this page?

Add your rating